Skip to main content
Clinical Trials/NCT05739201
NCT05739201
Recruiting
Not Applicable

Comparative Study Between Interscalene Nerve Block, Anterior Suprascapular Nerve Block, and Pericapsular Nerve Group Block for Arthroscopic Shoulder Surgery

Tanta University1 site in 1 country90 target enrollmentFebruary 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Interscalene Nerve Block
Sponsor
Tanta University
Enrollment
90
Locations
1
Primary Endpoint
the total opioid consumption.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study is designed to investigate the post-operative analgesic effect of interscalene nerve block or anterior suprascapular nerve block compared to pericapsular nerve group block in patient undergoing elective arthroscopic shoulder surgery.

Detailed Description

Shoulder arthroscopy is a common outpatient operation with an increasing number of indications and complexity. Early postoperative pain immediately following shoulder surgery is a major concern and cause of distress for patients and orthopedic surgeons. Adequate pain control is vital for all aspects of the patient's recovery. Nowadays, several ultrasound -guided regional anesthesia methods are used for postoperative analgesia. Regional techniques such as interscalene and supraclavicular blocks are usually preferred for shoulder analgesia. Interscalene brachial plexus block (ISB) is the gold standard technique in this area. Suprascapular nerve block (SSB) has been proposed as an alternative to the ISB in providing analgesia for shoulder surgeries as it has a lower likelihood of causing phrenic nerve blockade. The pericapsular nerve group (PENG) block has been suggested to be safely applied for analgesia and can be part of surgical anesthesia, but alone is not sufficient for anesthesia in shoulder surgery. The block of this area did not cause motor block or pulmonary complications, nor result in muscle laxity, blocking only the shoulder and the upper third of the humerus.

Registry
clinicaltrials.gov
Start Date
February 20, 2023
End Date
December 20, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shrouk Elsawaf

Resident

Tanta University

Eligibility Criteria

Inclusion Criteria

  • Adult patients.
  • ASA class I and II and scheduled for elective shoulder arthroscopy.

Exclusion Criteria

  • Patient who refuses the regional anesthesia technique.
  • History of allergy to local anesthetics.
  • Local infection at the site of the block.
  • History of Pre-existing major organ dysfunction such as hepatic and renal failure.
  • History of pre-existing lung disease (COPD, uncontrolled asthma).
  • Preexisting upper extremity neurological abnormality or neuropathy.
  • Difficulties in comprehending (NRS).
  • Chronic opioid users (opioid intake more than 3 months).

Outcomes

Primary Outcomes

the total opioid consumption.

Time Frame: 24-hour postoperatively

Postoperative analgesia will be assessed by total opioid consumption and time till administration of first rescue analgesia will be recorded.

Study Sites (1)

Loading locations...

Similar Trials